Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

HIV/AIDS

Almost 30% of UK men who have sex with men 'very likely' to use PrEP if it was available

Research shows there are an estimated 500,000 men who have sex with men in Europe who would be very likely to use pre-exposure HIV prophylaxis if it was made available to them.

pre exposure prophylaxis prep pills truvada

Source: Shutterstock.com

The UK has a PrEP gap of around 20% — just higher than the European average of 17.4%

Just under 10% of men who have sex with men (MSM) in the UK take pre-exposure HIV prophylaxis (PrEP), compared with almost 30% who say would be “very likely” to use PrEP if it was available to them, a paper published in Eurosurveillance (10 October 2019) has revealed.

The researchers, from the National AIDS Trust; London School of Hygiene and Tropical Medicine; and Public Health England, used data from the European Centre for Disease Prevention and Control monitoring and the European MSM Internet Study (EMIS-2017) to calculate the approximate PrEP gap — the difference between non-HIV diagnosed MSM who were “very likely” to use PrEP if it were accessible to them and the proportion of non-HIV diagnosed MSM who currently use PrEP from any available source — of each country.

They found that the UK has a PrEP gap of around 20%.

The estimated PrEP gap ranged from 44.8% in Russia to 4.3% in Portugal. An overall estimate of the PrEP gap for Europe was calculated as 17.4%, equating to 500,000 MSM who would be very likely to use PrEP, but were not currently able to access it.

England and Wales were two of seven countries that reported PrEP availability only through a pilot research project. However, the report said that degree of access to PrEP in such projects “varied considerably”; in the 12 months up to March 2019, England and Wales saw 6,000 people access PrEP compared to 125 people in Ukraine.

Scotland was one of 14 countries that reported that it provided reimbursed PrEP either through insurance or from the public sector.

Cost was found to be the most important barrier to implementing in countries where PrEP was not nationally available and reimbursed.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207199

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.